Paper · 18504331

Use of corticosteroids in treating infectious diseases.

McGee S and 1 other. Arch Intern Med, 2008. Cited by 95 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Use of corticosteroids in treating infectious diseases. Papers, record 18504331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18504331

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Use of corticosteroids in treating infectious diseases.; PubMed
Journal: Arch Intern Med; PubMed
Year: 2008; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/18504331/; PubMed
DOI: https://doi.org/10.1001/archinte.168.10.1034; PubMed
The journal: https://conductscience.org/library/journal-index/0372440; PubMed
Citations, by iCite: 95; iCite
Relative citation ratio, by iCite: 2.16; iCite
Revised in PubMed: 2008-05-27; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	McGee S	Steven
2	Hirschmann J	Jan

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Anti-Infective Agents	Major topic
Communicable Diseases	Major topic
Glucocorticoids	Major topic
CD4 Lymphocyte Count
Drug Therapy, Combination
HIV Infections
Humans
Treatment Outcome

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.

PMID	Title	Journal	Year	In Papers	Source
41,600,853	The Therapeutic Potential for Steroid Treatment Strategies in the Treatment of Murine Venezuelan Equine Encephalitis Virus (VEEV) Infection.	Viruses	2026	https://conductscience.org/library/papers/41600853	PubMed
41,146,788	Primary Varicella in an Adult Patient With Diabetes.	Cureus	2025	https://conductscience.org/library/papers/41146788	PubMed
41,134,367	Absence of submucosal edema and pseudopolyps on computed tomography in toxic megacolon is associated with increased mortality.	Abdom Radiol (NY)	2026	https://conductscience.org/library/papers/41134367	PubMed
40,817,233	Standard treatment regimen with and without dexamethasone on outcome of children aged 3-7 years with empyema: a randomized double blind clinical trial.	Ital J Pediatr	2025	https://conductscience.org/library/papers/40817233	PubMed
40,153,492	Steroid hormone levels vary with sex, aging, lifestyle, and genetics.	Sci Adv	2025	https://conductscience.org/library/papers/40153492	PubMed
38,813,741	A Rare Case of Widely Disseminated Syphilis.	Acta Derm Venereol	2024	https://conductscience.org/library/papers/38813741	PubMed
37,879,118	Shifting Tides: Is It Time to Embrace Adjunctive Corticosteroids for Community-Acquired Pneumonia?	Clin Infect Dis	2023	https://conductscience.org/library/papers/37879118	PubMed
37,487,610	The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).	Ann Rheum Dis	2023	https://conductscience.org/library/papers/37487610	PubMed
37,486,733	The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).	Arthritis Rheumatol	2023	https://conductscience.org/library/papers/37486733	PubMed
37,085,045	Controlling viral inflammatory lesions by inhibiting fatty acid metabolism.	Microbes Infect	2023	https://conductscience.org/library/papers/37085045	PubMed

1 to 10 of 53

See all 53 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
CD4	920	PubTator's text mining	https://conductscience.org/library/genes/920

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18504331

GET https://conductscience.org/api/papers/v1/18504331/cited_by?page=2

API reference For AI assistants